Overview
For patients with lung cancer, treatment does not end with surgery, chemotherapy, or radiation. Reducing the risk of recurrence, managing treatment side effects, supporting immune function, and improving quality of life are equally important goals — and these are areas where Traditional Chinese Medicine (TCM), integrated with Western oncology, offers evidence-based, clinically proven benefits. At Shanghai's leading integrative oncology centers, TCM and Western medicine are combined in a coordinated approach that has been shown to reduce post-surgical recurrence and metastasis risk by 27%.
China Medical Concierge Shanghai (CMCS) connects international patients with these specialists for comprehensive, whole-patient lung cancer care.
Understanding Lung Cancer & the Role of TCM
What Is Lung Cancer?
Lung cancer is the most common cancer and the leading cause of cancer death in China. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of cases. While surgery, targeted therapy, immunotherapy, and radiation have transformed outcomes for many patients, the risk of recurrence and metastasis remains significant — particularly for patients with locally advanced disease or those who have completed primary treatment.
The "Fu Zheng Zhi Ai" Philosophy: Strengthening the Body to Fight Cancer
The TCM approach to cancer treatment at Longhua Hospital is rooted in the principle of "Fu Zheng Zhi Ai" (扶正治癌) — "strengthening the body's vital energy (zheng qi) to fight cancer." This philosophy, developed by generations of National TCM Masters at Longhua Hospital, holds that cancer treatment must address not only the tumor itself, but also the patient's overall constitution, immune competence, and ability to tolerate and recover from Western treatment.
In practice, this means using individualized herbal medicine, acupuncture, and dietary therapy to:
- Reduce post-surgical recurrence and metastasis risk — clinical research shows a 27% reduction in recurrence/metastasis risk with TCM comprehensive treatment
- Support immune function — maintaining immune competence during and after chemotherapy, targeted therapy, and immunotherapy
- Reduce treatment side effects — chemotherapy-induced nausea, fatigue, peripheral neuropathy, and bone marrow suppression
- Improve quality of life — particularly for patients with advanced or metastatic disease
- Support long-term survivorship — TCM-based maintenance therapy to reduce recurrence risk after primary treatment completion
Common Symptoms of Lung Cancer
- Persistent cough or haemoptysis
- Chest pain or shortness of breath
- Hoarseness and unexplained weight loss
- Fatigue and recurrent respiratory infections
Integrative Treatment Approach
TCM During Surgery Recovery
After lung cancer surgery, TCM interventions — including herbal medicine and acupuncture — support wound healing, restore lung function, reduce post-operative fatigue, and accelerate return to normal activity. The "Fu Zheng" approach is particularly valuable in the post-surgical period, when the patient's vital energy has been depleted by the operation.
TCM During Chemotherapy & Targeted Therapy
During chemotherapy or targeted therapy, TCM is used as a supportive therapy to maintain treatment tolerance, reduce toxicity, and preserve quality of life. Herbal formulas are carefully selected to avoid interactions with Western drugs and to complement the mechanism of action of systemic therapy. Key benefits include reduction of chemotherapy-induced nausea, fatigue, and bone marrow suppression, and mitigation of targeted therapy-related skin toxicity and diarrhea.
TCM During Immunotherapy
For patients receiving immune checkpoint inhibitors, TCM may help modulate immune function and reduce the risk of immune-related adverse events (irAEs) — an area of active clinical research at Longhua Hospital.
TCM for Advanced & Metastatic Lung Cancer
For patients with advanced or metastatic lung cancer, TCM plays a particularly important role in maintaining quality of life, managing symptoms, and supporting immune function when curative treatment is no longer possible. Integrative palliative care — combining Western supportive care with TCM — is a distinctive strength of Shanghai's integrative oncology centers.
Reducing Recurrence Risk: The 27% Evidence
Clinical research led by Dr. Liu Lingshuang's team has demonstrated that TCM comprehensive treatment reduces the risk of post-surgical recurrence and metastasis in lung cancer patients by 27% — a clinically meaningful reduction that translates directly into improved long-term survival for patients who complete primary surgical treatment. This evidence base distinguishes Longhua Hospital's integrative oncology program from generic TCM approaches and positions it as a scientifically grounded complement to Western lung cancer treatment.
Why Choose Shanghai for Integrative Lung Cancer Care?
- National leadership in integrative oncology — Longhua Hospital is one of China's premier TCM hospitals and a national center of excellence for integrative cancer care
- "Fu Zheng Zhi Ai" lineage — treatment philosophy developed by National TCM Masters with decades of clinical evidence
- Evidence-based outcomes — 27% reduction in post-surgical recurrence/metastasis risk demonstrated in clinical research
- 2026 Shanghai Medical Craftsman recognition — the highest municipal honor for clinical excellence in Shanghai
- Cost-effective world-class care — significantly lower cost than equivalent treatment in the US, UK, or Singapore
Featured Specialist: Dr. Liu Lingshuang — Longhua Hospital, Shanghai University of TCM
Dr. Liu Lingshuang (刘苓霜) is a Chief Physician of Integrative Oncology at Longhua Hospital, Shanghai University of Traditional Chinese Medicine — one of China's premier TCM hospitals and a national center of excellence for integrative cancer care.
2026 Shanghai Medical Craftsman
Dr. Liu was honored as a 2026 "Shanghai Medical Craftsman" (上海医务工匠) — the highest municipal recognition for clinical excellence, craftsmanship, and dedication to patient care in Shanghai. This award reflects both the quality of her clinical work and her commitment to advancing integrative oncology.
Lineage: National TCM Master "Fu Zheng Zhi Ai"
Dr. Liu trained under a National TCM Master (国医大师) — China's highest designation for TCM practitioners — in the "Fu Zheng Zhi Ai" tradition of strengthening the body's vital energy to fight cancer. This lineage connects her clinical practice to decades of accumulated wisdom and clinical experience in TCM-based cancer treatment, refined and validated through modern clinical research.
Evidence-Based Clinical Research
Dr. Liu's team has conducted rigorous clinical research demonstrating that TCM comprehensive treatment reduces post-surgical recurrence and metastasis risk in lung cancer patients by 27% — providing the highest level of evidence for the clinical benefit of integrative TCM-Western treatment in lung cancer survivorship.
Clinical Expertise
- TCM-Western integrative treatment of lung cancer — coordinated TCM and Western oncology care across all stages of disease
- "Fu Zheng Zhi Ai" herbal medicine — individualized herbal formulas to strengthen vital energy and reduce recurrence risk
- Post-surgical TCM support — recovery optimization and long-term recurrence prevention
- TCM during chemotherapy, targeted therapy, and immunotherapy — side effect management and treatment tolerance support
- Quality of life improvement — TCM-based supportive care for advanced and metastatic disease
For international patients, Dr. Liu's team offers remote pre-consultation review of medical records and prior treatment history, enabling a personalized integrative treatment plan to be developed before arrival in Shanghai.
How CMCS Supports Your Journey
CMCS is not a hospital — we are your dedicated medical concierge, providing a trusted bridge between international patients and Shanghai's finest cancer specialists.
Our services include:
- ✅ Direct appointment coordination with Dr. Liu Lingshuang and the Longhua Hospital integrative oncology team
- ✅ Medical record translation and pre-consultation review
- ✅ Second opinion facilitation
- ✅ Treatment scheduling and hospital coordination support
- ✅ Accommodation and logistics coordination in Shanghai
- ✅ Post-treatment follow-up and remote check-in support
Contact CMCS
If you or a loved one has been diagnosed with lung cancer and would like to explore integrative TCM-Western treatment options in Shanghai, our team is ready to help.
📧 Email: contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 Website: www.medicalsh.com
CMCS — China Medical Concierge Shanghai. Connecting international patients with Shanghai's finest specialists.
0 commentaire